Tenaya Therapeutics, Inc.TNYANASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P35
Within normal range
vs 3Y Ago
-0.4x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -3.68% |
| Q3 2025 | -11.55% |
| Q2 2025 | -17.58% |
| Q1 2025 | 12.78% |
| Q4 2024 | -8.17% |
| Q3 2024 | -10.15% |
| Q2 2024 | -9.60% |
| Q1 2024 | 9.58% |
| Q4 2023 | -0.98% |
| Q3 2023 | -12.79% |
| Q2 2023 | 3.41% |
| Q1 2023 | -0.56% |
| Q4 2022 | 8.38% |
| Q3 2022 | 13.81% |
| Q2 2022 | -13.57% |
| Q1 2022 | 15.28% |
| Q4 2021 | 61.87% |
| Q3 2021 | 18.69% |
| Q2 2021 | 13.72% |
| Q1 2021 | 14.66% |
| Q4 2020 | -1.37% |
| Q3 2020 | 21.87% |
| Q2 2020 | -4.65% |
| Q1 2020 | 0.00% |